Skip to content

10x Genomics, Inc. TXG Software Development — Contractual obligation

Similar metrics at other companies

Oracle logo
ORCLSoftware — Contract With Customer Liability Current
$5.66B+5.8%
Workday, Inc. logo
WDAYContract Liabilities
$70M+7.7%
Rubrik logo
RBRKContract Liabilities
$766.4M+14.3%
Globalstar logo
GSATContract Liabilities
$837.65M+157%
JFrog Ltd. logo
FROGContract Liabilities
$30.34M+19.4%
Okta, Inc. logo
OKTAContract Liabilities
$23M+15.0%

Other financials

Income statement

See full
Revenue$150.8M-2.6%
Gross profit$106.2M+0.7%
Operating income-$17.0M+56.7%
Net income-$13.5M+60.8%
EPS (diluted)-$0.10+64.3%

Balance sheet

See full
Cash & equivalents$490.3M+30.0%
Total debt$81.4M+1.6%
Total equity$814.3M+15.2%
Total assets$1.0B+12.4%

Cash flow

See full
Operating cash flow$26.1M-24.0%
CapEx$1.6M-15.6%
Free cash flow$24.5M-24.4%

Valuation

See full
Market cap$4.41B+154%

Profitability

See full
Gross margin69.6%+1.2pp
Operating margin-6.1%-2.7pp
Net margin-3.5%-1.6pp
FCF margin19.1%

Returns & leverage

See full
Return on equity-3%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ContractualObligation.

The official record: 10x Genomics, Inc.’s 10-K, filed February 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s software development — contractual obligation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 10x Genomics, Inc.'s software development — contractual obligation?
10x Genomics, Inc. (TXG) reported software development — contractual obligation of $18.6M in Q4 2025.
How has 10x Genomics, Inc.'s software development — contractual obligation changed year-over-year?
10x Genomics, Inc.'s software development — contractual obligation decreased by 5.1% year-over-year, from $19.6M to $18.6M.
What does software development — contractual obligation mean?
This metric represents the total value of future payment obligations or service commitments specifically tied to the software development segment. It reflects the long-term revenue visibility or financial liability associated with software-related contracts and licensing agreements. Monitoring this figure helps investors assess the stability and predictability of the software business model within the broader life science technology portfolio.